Books Related Topics 
Drug Patent Watch
JUNE 17, 2025
Meet the Orange Book, a treasure trove of data that holds the secrets to pharmaceutical competitive intelligence. With its comprehensive list of approved drugs, patent information, and regulatory details, the Orange Book is an untapped goldmine of insights waiting to be mined.
FDA Law Blog: Biosimilars
APRIL 8, 2025
OGDP is one of several offices in OGD, and it was composed of three divisions: the Division of Legal and Regulatory Support, the Division of Orange Book Publication and Regulatory Assessment, and the Division of Policy Development (DPD). Providing significant policy support to the annual update of the Orange Book Preface.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
MAY 15, 2025
"Unlocking the Secrets of the FDA's Orange and Purple Books: Insider Tips from a Drug Patent Research Expert As the pharmaceutical industry continues to evolve at breakneck speed, staying ahead of the curve requires more than just a keen eye for innovation it demands a deep understanding of the regulatory landscape.
STAT
FEBRUARY 17, 2025
By offering travelers the ability to compare prices and book accommodations from thousands of options, OTAs brought convenience, transparency, and lower costs. Today, over half of hotel bookings flow through OTAs, leaving hotels with slimmer margins and less control over their customer relationships.
ALiEM - Pharm Pearls
OCTOBER 30, 2024
2023 [book]. This month in JAAD Case Reports: August 2023: Xylazine and skin necrosis. Journal of the American Academy of Dermatology. 2023 Aug 1;89(2):231. DOI: Papudesi BN, Malayala SV, Regina AC. Xylazine toxicity. PMID 37603662 Rose L, Kirven R, Tyler K, Chung C, Korman AM. JAAD Case Reports. 2023 Jun 1;36:113-5.
RX Note
JULY 19, 2025
Introduction Years ago, I came across reference books that began with a preface explaining how to make the most of the book itself. At that time, I found myself wondering, why would anyone need such a guide? Is not learning simply a matter of reading through the pages?
Express Pharma
MAY 11, 2025
Jawa Capital Services is the Book Running Lead Manager, Socradamus Capital is the Underwriter to the Issue, and Kfin Technologies is the Registrar to the Issue. Lakh Equity Shares with a face value of 10/- through the book-building route. The IPO will comprise a fresh issue of 29.46
Expert insights. Personalized for you.
66 
Let's personalize your content